Atlas Trials

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Clinical trial NCT00432042 · COMPLETED

Trial details

NCT number
NCT00432042
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
VaricellaMeaslesMumpsRubellaDiphtheriaTetanusPertussisPoliomyelitisHepatitis BHaemophilus Infections
Start date
2007-01-12
Primary completion
2008-03-27
Enrollment
955

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.